Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

4.420

+0.040 (0.91%)

At close: Mar 20, 2026, 4:00 PM EDT

4.550

+0.130 (2.94%)

After-hours: Mar 20, 2026, 7:59 PM EDT

Grace Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 20, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	68	31	32	21	54	120
Market Cap Growth	149.62%	-2.84%	56.90%	-62.03%	-55.00%	250.73%
Enterprise Value	50	20	7	-10	8	92
Last Close Price	4.42	2.28	3.42	2.76	7.32	28.80
PS Ratio	-	-	-	-	-	612.61
PB Ratio	1.05	0.47	0.52	0.30	0.50	2.16
P/TBV Ratio	4.38	1.81	2.58	1.10	2.12	2.16
EV/Sales Ratio	-	-	-	-	-	470.71
Debt / Equity Ratio	-	-	-	0.01	0.00	0.00
Net Debt / Equity Ratio	-0.29	-0.33	-0.37	-0.40	-0.40	-1.09
Net Debt / EBITDA Ratio	1.66	1.33	2.04	1.52	3.87	6.19
Net Debt / FCF Ratio	1.84	1.49	1.86	1.72	2.52	4.22
Asset Turnover	-	-	-	-	-	0.01
Quick Ratio	14.56	11.53	14.09	8.41	13.56	38.80
Current Ratio	14.96	11.77	14.26	8.59	13.89	39.50
Return on Equity (ROE)	-10.22%	-14.91%	-19.82%	-48.15%	-11.98%	-57.33%
Return on Assets (ROA)	-10.84%	-14.35%	-9.25%	-10.96%	-7.94%	-15.70%
Return on Capital Employed (ROCE)	-16.70%	-23.80%	-15.70%	-24.00%	-9.70%	-17.60%
Earnings Yield	-8.74%	-30.59%	-39.92%	-206.80%	-18.17%	-16.39%
FCF Yield	-14.81%	-47.65%	-38.38%	-77.64%	-31.90%	-11.98%
Buyback Yield / Dilution	-36.09%	-26.85%	-28.16%	-21.09%	-148.46%	-40.25%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q